Suppr超能文献

肌肉骨骼局部药物输送的最新进展。

Recent advances in musculoskeletal local drug delivery.

机构信息

Department of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV 26506-9196, United States.

Department of Mechanical Engineering, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.

出版信息

Acta Biomater. 2019 Jul 15;93:135-151. doi: 10.1016/j.actbio.2019.01.043. Epub 2019 Jan 24.

Abstract

Musculoskeletal disorders are a significant burden on the global economy and public health. Advanced drug delivery plays a key role in the musculoskeletal field and holds the promise of enhancing the repair of degenerated and injured musculoskeletal tissues. Ideally, drug delivery should have the ability to directly deliver therapeutic agents to the diseased/injured sites with a desirable drug level over a period of time. Here, we present a mini-review of the current state-of-the-art research associated with local drug delivery and its use for the treatment of musculoskeletal disorders. First, an overview of drug delivery strategies, with a focus on issues related to musculoskeletal pathology, potential therapeutic strategies, conventional and non-conventional drugs, and various delivery systems, is introduced. Then, we highlight recent advances in the emerging fields of musculoskeletal local drug delivery, involving therapeutic drugs (e.g., genes, small molecule therapeutics, and stem cells), novel delivery vehicles (e.g., 3D printing and tissue engineering techniques), and innovative delivery approaches (e.g., multi-drug delivery and smart stimuli-responsive delivery). The review concludes with future perspectives and associated challenges for developing local drug delivery for musculoskeletal applications. STATEMENT OF SIGNIFICANCE: Three important aspects are highlighted in this manuscript: 1) The advanced musculoskeletal drug delivery is introduced from the aspects ranging from musculoskeletal disorders, potential therapeutic solutions, and various drug delivery systems. 2) The recent advances in the emerging fields of musculoskeletal local drug delivery, involving therapeutic drugs (e.g., genes, small molecule therapeutics, and stem cells), novel delivery vehicles (e.g., 3D printing and tissue engineering technique), and innovative delivery approaches (e.g., multi-drug delivery and smart stimuli-responsive delivery), are highlighted. 3) The challenges and perspectives of future research directions in the development of musculoskeletal local drug delivery are presented.

摘要

肌肉骨骼疾病是全球经济和公共卫生的重大负担。先进的药物输送在肌肉骨骼领域中起着关键作用,有望增强退变和受损肌肉骨骼组织的修复。理想情况下,药物输送应该能够将治疗剂直接递送到患病/受伤部位,并在一段时间内保持理想的药物水平。在这里,我们对与局部药物输送相关的最新研究进展进行了简要回顾,并探讨了其在肌肉骨骼疾病治疗中的应用。首先,我们介绍了药物输送策略的概述,重点介绍了与肌肉骨骼病理学相关的问题、潜在的治疗策略、常规和非传统药物以及各种输送系统。然后,我们强调了肌肉骨骼局部药物输送领域的最新进展,涉及治疗药物(如基因、小分子治疗药物和干细胞)、新型输送载体(如 3D 打印和组织工程技术)和创新的输送方法(如多药物输送和智能刺激响应性输送)。最后,本文总结了未来的展望以及开发肌肉骨骼应用局部药物输送所面临的挑战。

意义陈述:本文强调了三个重要方面:1)从肌肉骨骼疾病、潜在治疗解决方案和各种药物输送系统等方面介绍了先进的肌肉骨骼药物输送。2)突出了肌肉骨骼局部药物输送新兴领域的最新进展,涉及治疗药物(如基因、小分子治疗药物和干细胞)、新型输送载体(如 3D 打印和组织工程技术)和创新的输送方法(如多药物输送和智能刺激响应性输送)。3)提出了肌肉骨骼局部药物输送开发未来研究方向的挑战和展望。

相似文献

1
Recent advances in musculoskeletal local drug delivery.
Acta Biomater. 2019 Jul 15;93:135-151. doi: 10.1016/j.actbio.2019.01.043. Epub 2019 Jan 24.
2
Gelatin Methacryloyl Hydrogels for Musculoskeletal Tissue Regeneration.
Bioengineering (Basel). 2022 Jul 21;9(7):332. doi: 10.3390/bioengineering9070332.
3
Cell delivery therapeutics for musculoskeletal regeneration.
Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):765-83. doi: 10.1016/j.addr.2010.04.004. Epub 2010 Apr 14.
4
Bio-instructive materials for musculoskeletal regeneration.
Acta Biomater. 2019 Sep 15;96:20-34. doi: 10.1016/j.actbio.2019.07.014. Epub 2019 Jul 11.
5
Small molecule delivery through nanofibrous scaffolds for musculoskeletal regenerative engineering.
Nanomedicine. 2014 Nov;10(8):1691-9. doi: 10.1016/j.nano.2014.05.013. Epub 2014 Jun 5.
6
Functionalized hydrogels as smart gene delivery systems to treat musculoskeletal disorders.
Adv Colloid Interface Sci. 2024 Sep;331:103232. doi: 10.1016/j.cis.2024.103232. Epub 2024 Jun 14.
7
3D printing of electrically conductive hydrogels for tissue engineering and biosensors - A review.
Acta Biomater. 2020 Jan 1;101:1-13. doi: 10.1016/j.actbio.2019.08.044. Epub 2019 Aug 30.
8
Engineering Stem and Stromal Cell Therapies for Musculoskeletal Tissue Repair.
Cell Stem Cell. 2018 Mar 1;22(3):325-339. doi: 10.1016/j.stem.2018.01.014. Epub 2018 Feb 8.
9
Stem Cells for Treatment of Musculoskeletal Conditions - Orthopaedic/Sports Medicine Applications.
Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165624. doi: 10.1016/j.bbadis.2019.165624. Epub 2019 Nov 30.
10
Stimuli-Responsive Delivery of Growth Factors for Tissue Engineering.
Adv Healthc Mater. 2020 Apr;9(7):e1901714. doi: 10.1002/adhm.201901714. Epub 2020 Mar 3.

引用本文的文献

1
Refined ADME Profiles for ATC Drug Classes.
Pharmaceutics. 2025 Feb 28;17(3):308. doi: 10.3390/pharmaceutics17030308.
3
Therapeutic Controlled Release Strategies for Human Osteoarthritis.
Adv Healthc Mater. 2025 Jan;14(2):e2402737. doi: 10.1002/adhm.202402737. Epub 2024 Nov 6.
4
Advancements in Drug Delivery Systems for the Treatment of Sarcopenia: An Updated Overview.
Int J Mol Sci. 2024 Oct 7;25(19):10766. doi: 10.3390/ijms251910766.
5
Musculoskeletal Organs-on-Chips: An Emerging Platform for Studying the Nanotechnology-Biology Interface.
Adv Mater. 2025 Jan;37(2):e2401334. doi: 10.1002/adma.202401334. Epub 2024 Mar 28.
6
Smart Strategies to Overcome Drug Delivery Challenges in the Musculoskeletal System.
Pharmaceuticals (Basel). 2023 Jul 6;16(7):967. doi: 10.3390/ph16070967.
9
Growth Factor Immobilization Strategies for Musculoskeletal Disorders.
Curr Osteoporos Rep. 2022 Feb;20(1):13-25. doi: 10.1007/s11914-022-00718-x. Epub 2022 Feb 4.
10
Delivery of transcription factors as modulators of cell differentiation.
Drug Deliv Transl Res. 2021 Apr;11(2):426-444. doi: 10.1007/s13346-021-00931-8. Epub 2021 Feb 20.

本文引用的文献

1
Biodegradable poly(ε-caprolactone) as a controlled drug delivery vehicle of vancomycin for the treatment of MRSA infection.
J Mater Chem B. 2016 Aug 14;4(30):5151-5160. doi: 10.1039/c6tb01623e. Epub 2016 Jul 15.
2
Dendrimers for drug delivery.
J Mater Chem B. 2014 Jul 14;2(26):4055-4066. doi: 10.1039/c4tb00171k. Epub 2014 Jun 2.
3
Multidrug-eluting bi-layered microparticle-mesh scaffolds for musculoskeletal tissue regeneration.
J Mater Chem B. 2018 May 28;6(20):3340-3347. doi: 10.1039/c8tb00397a. Epub 2018 May 10.
4
Capsule-Integrated Polypeptide Multilayer Films for Effective pH-Responsive Multiple Drug Co-Delivery.
ACS Appl Mater Interfaces. 2018 Dec 26;10(51):44267-44278. doi: 10.1021/acsami.8b17264. Epub 2018 Dec 14.
5
A bone-targeting delivery system carrying osteogenic phytomolecule icaritin prevents osteoporosis in mice.
Biomaterials. 2018 Nov;182:58-71. doi: 10.1016/j.biomaterials.2018.07.046. Epub 2018 Aug 6.
6
Editorial overview: Musculoskeletal: New therapeutic targets and delivery systems.
Curr Opin Pharmacol. 2018 Jun;40:ix-xi. doi: 10.1016/j.coph.2018.06.002.
7
Reducing the global burden of musculoskeletal conditions.
Bull World Health Organ. 2018 May 1;96(5):366-368. doi: 10.2471/BLT.17.204891. Epub 2018 Apr 12.
8
Engineering Stem and Stromal Cell Therapies for Musculoskeletal Tissue Repair.
Cell Stem Cell. 2018 Mar 1;22(3):325-339. doi: 10.1016/j.stem.2018.01.014. Epub 2018 Feb 8.
9
Programmed biomolecule delivery to enable and direct cell migration for connective tissue repair.
Nat Commun. 2017 Nov 24;8(1):1780. doi: 10.1038/s41467-017-01955-w.
10
Application of kartogenin for musculoskeletal regeneration.
J Biomed Mater Res A. 2018 Apr;106(4):1141-1148. doi: 10.1002/jbm.a.36300. Epub 2017 Dec 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验